Quantcast
Channel: BioTuesdays » ITCI
Browsing all 2 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Leerink ups Intra-Cellular target to $34 from $13

Leerink Partners has raised its price target for “outperform-rated” Intra-Cellular Therapies (NASDAQ:ITCI) to $34 from $13, after making adjustments to the revenue and expense lines in its model, which...

View Article



Image may be NSFW.
Clik here to view.

Leerink ups Intra-Cellular price target to $35

Leerink Partners has raised its price target for “outperform-rated” Intra-Cellular Therapies (NASDAQ:ITCI) to $35 from $34 in assumed coverage. The stock closed at $15.98 on Tuesday. Intra-Cellular has...

View Article
Browsing all 2 articles
Browse latest View live




Latest Images